Director dealings: Oxford Biomedica chair ups stake

(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date. Doliveux, has been at the helm of the board since 2020, bought 20,250 shares at a price of 505p each, spending a total of £102,262.50.

OXB's share price closed Wednesday's session at 481p, having lost over a quarter of its value since the start of 2026.

After the latest purchase, Oxford Biomedica said Doliveux owns 459,055 shares, equivalent to 0.379% of the company's issued share capital.



Top Director Buys

Oxford Biomedica (OXB) Director name: Doliveux,Roch Amount purchased: 20,250 @ 505.00p Value: £102,262.50

St James's Place (STJ) Director name: Manduca,Paul Amount purchased: 3,624 @ 1,097.73p Value: £39,781.55

St James's Place (STJ) Director name: Manduca,Paul Amount purchased: 3,624 @ 1,097.73p Value: £39,781.55

Trufin (TRU) Director name: Bergh,James van den Amount purchased: 30,000 @ 97.57p Value: £29,271.00

Gresham House Energy Storage Fund (GRID) Director name: Stevenson ,David Amount purchased: 8,610 @ 98.10p Value: £8,446.41

Activeops (AOM) Director name: Jeffery,Richard John Amount purchased: 73 @ 205.00p Value: £149.65

St James's Place (STJ) Director name: FitzPatrick,Mark Amount purchased: 4 @ 1,125.23p Value: £45.01

St James's Place (STJ) Director name: Manduca,Paul Amount purchased: 2 @ 1,125.23p Value: £22.50